During Women's Health Month, Hone Health launched the Menopause Time Off Movement, calling on employers to recognize menopause as a legitimate workforce health issue that affects millions of women during their peak earning and leadership years. According to a 2026 Hone Health survey of 1,028 women in the United States between the ages of 30 and 60, nearly 90% reported that at least one menopause symptom impacted their work, and 62% said they avoided taking time off or asking for accommodations because menopause is not explicitly recognized in workplace policy.
As part of the Menopause Time Off Movement, Hone is launching the MTO Fund, giving away 50 $1,000 microgrants to individuals navigating menopause without access to paid leave, so they can take time to rest or seek medical care.
Menopause Workplace Initiatives
The Menopause Time Off Movement Asks for Employer Recognition
Trend Themes
-
Menopause Time-off Recognition — Recognition of menopause as a distinct workplace health category creates opportunities for new policy frameworks and leave models tailored to midcareer employees.
-
Menopause-focused Benefits Design — Specialized benefits packages that incorporate symptom management, flexible scheduling, and targeted financial support are emerging as differentiators in talent retention.
-
Workplace Health Equity Data Insights — Granular measurement of menopause-related absenteeism and productivity impacts is enabling data-driven benefit customization and employer benchmarking.
Industry Implications
-
HR Technology Platforms — Next-generation HR systems integrating policy libraries, accommodation workflows, and stigma-reduction communications are positioned to reshape employer responses to menopause.
-
Employee Benefits & Insurance — Insurers and benefits brokers offering microgrants, short-term paid leave products, and condition-specific coverage are positioned to capture unmet demand among midcareer women.
-
Telehealth & Femtech — Digital health services focused on menopause symptom tracking, remote consults, and personalized treatment pathways are poised to disrupt traditional care access models.